CALLIO THERAPEUTICS Trademark
Trademark Overview
On Tuesday, August 26, 2025, a trademark application was filed for CALLIO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CALLIO THERAPEUTICS trademark a serial number of 99357982. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, June 5, 2026. This trademark is owned by Callio Operating Co, Inc.. The CALLIO THERAPEUTICS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others.
Pharmaceutical and biological preparations for treating cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies for treating cancer; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of cancer for clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology for treating cancer
Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
General Information
| Serial Number | 99357982 |
| Word Mark | CALLIO THERAPEUTICS |
| Filing Date | Tuesday, August 26, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Friday, June 5, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Description of Mark | The mark consists of a squiggly design element to the left of the word "callio" that is above the word "THERAPEUTICS". |
| Goods and Services | Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others. |
| Goods and Services | Pharmaceutical and biological preparations for treating cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies for treating cancer; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of cancer for clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology for treating cancer |
| Goods and Services | Custom manufacturing of pharmaceuticals and therapeutic agents for medical use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 26, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 26, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 26, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Callio Operating Co, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98101
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 26, 2025 | NEW APPLICATION ENTERED |
| Tuesday, August 26, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 14, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 14, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 15, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, January 21, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 21, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 21, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 21, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 21, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 5, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
